Results 71 to 80 of about 15,758,896 (298)

Semantics matter: Why the European Monetary Fund is a welcome idea, but a bad name. Egmont Commentary, 11 January 2018 [PDF]

open access: yes, 2018
The willingness to complete our Economic and Monetary Union has been given much welcome impetus in recent months. One of the key ideas is to transform the existing European Stability Mechanism (ESM), which provides conditional financial assistance to ...
Verhelst, Stijn
core  

Metastatic niche shaped by host factors influences disseminated cancer cell fate

open access: yesFEBS Letters, EarlyView.
Metastasis is shaped not only by cancer cells but also by the environments they encounter. This review explores how factors such as aging, diet, the microbiome, lifestyle, and environmental exposures remodel organ‐specific niches in the lung, liver, bone, and brain, influencing where metastatic cells survive, remain dormant, or grow, and ultimately ...
Gwennan Delyth Ward   +2 more
wiley   +1 more source

Convergence Instruments of Western Balkan Countries

open access: yesEconomic Analysis, 2017
The fundamental objective of the EU regional policy is to reduce differences in development between regions in Europe. EU is directing structural funds to the regions which need help, and in that way EU helps to raise the level of employment and living ...
Marko Tomljanović   +2 more
doaj  

Pension Fund Capitalism and Financial Crisis. IHS Political Science Series 126, December 2011 [PDF]

open access: yes, 2011
Basic public pension schemes and cut backs in earnings-related public pensions led to an increasing role of supplementary pensions such as pension funds for old-age incomes.
Wiß, Tobias
core  

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression

open access: yesMolecular Oncology, EarlyView.
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge   +17 more
wiley   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

open access: yesMolecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla   +9 more
wiley   +1 more source

Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients

open access: yesMolecular Oncology, EarlyView.
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner   +14 more
wiley   +1 more source

Rileggendo "La forza delle idee". (Reading “La forza delle idee”)

open access: yesMoneta e Credito, 2010
The article, in memory of Ezio Tarantelli, discusses the relevance today of a number of his ideas and proposals on economic policy. Among these, the reduction of working time and the opportunity to create a European currency that would finance the ...
Mario Sarcinelli
doaj   +1 more source

The European Social Fund and the EU: Flexibility, growth, stability

open access: yes, 2002
This book is based on an original and sustained analysis of European Commission policy texts related to the European Social Fund (ESF) and its broader educational, socio-economic and political context. The work is based on a rigorous library and internet
Brine, Jacky
core  

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy